149 related articles for article (PubMed ID: 8596656)
1. Effects of haloperidol, clozapine and citalopram on messenger RNA levels of chromogranins A and B and secretogranin II in various regions of rat brain.
Kroesen S; Marksteiner J; Mahata SK; Mahata M; Fischer-Colbrie R; Saria A; Kapeller I; Winkler H
Neuroscience; 1995 Dec; 69(3):881-91. PubMed ID: 8596656
[TBL] [Abstract][Full Text] [Related]
2. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine.
Werme M; Ringholm A; Olson L; Brené S
Brain Res; 2000 Apr; 863(1-2):112-9. PubMed ID: 10773199
[TBL] [Abstract][Full Text] [Related]
3. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.
See RE; Lynch AM; Sorg BA
Neuroscience; 1996 May; 72(1):99-104. PubMed ID: 8730709
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum.
Merchant KM; Dobner PR; Dorsa DM
J Neurosci; 1992 Feb; 12(2):652-63. PubMed ID: 1531499
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol.
Yu J; Källström L; Wiesel FA; Johnson AE
Synapse; 1999 Dec; 34(3):192-207. PubMed ID: 10523757
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions.
Radke JM; Owens MJ; Ritchie JC; Nemeroff CB
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11462-4. PubMed ID: 9736759
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens, and frontal cortex of the rat.
Salin P; Mercugliano M; Chesselet MF
Cell Mol Neurobiol; 1990 Mar; 10(1):127-44. PubMed ID: 1970756
[TBL] [Abstract][Full Text] [Related]
8. The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone.
Fujimura M; Hashimoto K; Yamagami K
Life Sci; 2000 Oct; 67(23):2865-72. PubMed ID: 11106001
[TBL] [Abstract][Full Text] [Related]
9. Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin1A receptors.
Ase AR; Amdiss F; Hébert C; Huang N; van Gelder NM; Reader TA
J Neural Transm (Vienna); 1999; 106(1):75-105. PubMed ID: 10195336
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
Robertson GS; Fibiger HC
Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
[TBL] [Abstract][Full Text] [Related]
11. Ontogenic development and distribution of mRNAs of chromogranin A and B, secretogranin II, p65 and synaptin/synaptophysin in rat brain.
Mahata M; Mahata SK; Fischer-Colbrie R; Winkler H
Brain Res Dev Brain Res; 1993 Nov; 76(1):43-58. PubMed ID: 8306430
[TBL] [Abstract][Full Text] [Related]
12. Increase of dialysate dopamine in the bed nucleus of stria terminalis by clozapine and related neuroleptics.
Carboni E; Rolando MT; Silvagni A; Di Chiara G
Neuropsychopharmacology; 2000 Feb; 22(2):140-7. PubMed ID: 10649827
[TBL] [Abstract][Full Text] [Related]
13. Effects of atypical antipsychotic drugs vs. haloperidol on expression of heat shock protein in the discrete brain regions of phencyclidine-treated rats.
Nakahara T; Kuroki T; Hondo H; Tsutsumi T; Fukuda K; Yao H; Uchimura H
Brain Res Mol Brain Res; 1999 Nov; 73(1-2):193-7. PubMed ID: 10581414
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization of neuroleptic-sensitive neurons in the forebrain: contrasting targets of haloperidol and clozapine.
Guo N; Vincent SR; Fibiger HC
Neuropsychopharmacology; 1998 Aug; 19(2):133-45. PubMed ID: 9629567
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic drug treatment induces differential gene expression in the rat cortex.
Kontkanen O; Törönen P; Lakso M; Wong G; Castrén E
J Neurochem; 2002 Dec; 83(5):1043-53. PubMed ID: 12437575
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats.
Huang XF; Deng C; Zavitsanou K
Neuropeptides; 2006 Jun; 40(3):213-9. PubMed ID: 16516965
[TBL] [Abstract][Full Text] [Related]
17. Effects of clozapine and haloperidol on 5-HT6 receptor mRNA levels in rat brain.
Frederick JA; Meador-Woodruff JH
Schizophr Res; 1999 Jul; 38(1):7-12. PubMed ID: 10427606
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin mRNA levels in the brain as a marker for acute and chronic changes in neuronal activity: effect of treatments including seizures, osmotic stimulation and axotomy in the rat.
Shen PJ; Gundlach AL
Eur J Neurosci; 1996 May; 8(5):988-1000. PubMed ID: 8743747
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment.
Marksteiner J; Weiss U; Weis C; Laslop A; Fischer-Colbrie R; Humpel C; Feldon J; Fleischhacker WW
Neuroscience; 2001; 104(2):325-33. PubMed ID: 11377837
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.
Duncan GE; Leipzig JN; Mailman RB; Lieberman JA
Brain Res; 1998 Nov; 812(1-2):65-75. PubMed ID: 9813244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
